
Alignment shows a smaller Medicare Advantage player can achieve profitability and growth despite industry‑wide cost pressures, reshaping competitive dynamics.
The Medicare Advantage segment has entered a turbulent phase as larger insurers grapple with rising claim costs and shrinking profit margins. Post‑pandemic demand has flooded plans with patients who delayed care, driving medical expense inflation across the board. In this environment, Alignment Healthcare has distinguished itself by not only preserving enrollment but accelerating it, reporting a 25 percent jump in members to 236,300 at quarter‑end. The company’s ability to grow while many competitors are pulling back geographically underscores a strategic emphasis on scale and senior‑focused care delivery.
Financially, Alignment turned a $31 million Q4 loss in 2024 into an $11 million loss in 2025, while revenue surged 44 percent to just over $1 billion. More telling is the medical benefits ratio, which slipped marginally to 87.7 percent—well under the 90 percent‑plus levels reported by most peers. This tighter ratio indicates that the firm is converting a larger share of premiums into profit rather than medical spend, a rare achievement in a cost‑escalating market. The company also generated free cash flow for the full year, bolstering its balance sheet and funding further expansion.
Looking ahead, Alignment set 2026 revenue guidance between $5.14 billion and $5.19 billion, implying 30‑31 percent year‑over‑year growth, and projected adjusted EBITDA of $133 million to $163 million. The guidance reflects both organic enrollment gains and the company’s decision to broaden its state‑by‑state footprint, a contrast to rivals that are retreating. For investors, the combination of disciplined cost management, expanding member base, and robust cash generation positions Alignment as a potential outlier in the Medicare Advantage space. Industry watchers will monitor whether its model can sustain profitability as claim pressures intensify.
Comments
Want to join the conversation?
Loading comments...